Indian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...

Private equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per sha...

Indian stock markets face ongoing volatility from West Asian geopolitical events. Despite this, earnings prospects remain strong. Investors...

The Reserve Bank of India has introduced measures to boost foreign currency inflows, including incentives for external commercial borrowing...

Around 16 equity mutual funds delivered impressive returns over the last five years. These funds multiplied investors' lumpsum investments ...

The Indian rupee is dipping to historic lows, approaching the 100-dollar threshold. Driven by market sentiment and a perilous cycle of fore...

South Korea's stock market has surged past India's, becoming the world's sixth-largest, driven by its semiconductor giants' AI boom. India ...

Foreign investors' cumulative net equity investments in India have fallen to their lowest level since 2016 after sustained selling, undersc...

Axis Securities retained a bullish view on Indian equities and recommended 15 stocks for June across market capitalisations, with potential...

Indian stock markets experienced a sharp decline on Monday. The Sensex and Nifty both fell significantly. This downturn was driven by subst...

Market veteran Ambareesh Baliga sees Indian equities well-positioned if geopolitical tensions ease and macro conditions remain supportive. ...

Foreign portfolio investors offloaded Indian equities worth a net Rs 20,637 crore on Friday, marking one of the sharpest single-day selloff...

Equity mutual funds saw strong performance in May, with returns reaching up to 17%. International funds led the gains, driven by markets li...

The economic horizon of India is clouded by a dual predicament characterized by a lack of financial resources and innovative ideas. While r...

A global AI-led market shift is driving massive foreign capital outflows from India toward East Asia’s technology hubs, with overseas inves...

An investor's mutual fund portfolio was reviewed, revealing a need for better alignment with long-term goals. Experts advised shifting focu...

Sun Pharma is expected to post double-digit revenue growth in Q4FY26, driven by strong performance across speciality drugs, domestic formul...